<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Voyager Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Voyager Therapeutics, Inc.

    Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $360,000,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Andre Turenne
    • FOUNDED
      2013
    • EMPLOYEES
      101-250
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Soliton, Inc

    Soliton, Inc

    Soliton, Inc. is a medical device company with a novel and proprietary platform te...

    Soliton, Inc. is a medical device company with ...

    Fundraising Status:    EC
    Filing Type:    RARD
    NextCure, Inc.

    NextCure, Inc.

    NextCure is a clinical-stage biopharmaceutical company committed to discovering an...

    NextCure is a clinical-stage biopharmaceutical ...

    Filing Type:    PU
    DarioHealth Corp.

    DarioHealth Corp.

    DarioHealth Corp. (NASDAQ: DRIO) is a leading global Digital Therapeutics (DTx) co...

    DarioHealth Corp. (NASDAQ: DRIO) is a leading g...

    Filing Type:    PU
    Oramed Pharmaceuticals Inc.

    Oramed Pharmaceuticals Inc.

    Oramed Pharmaceuticals (NASDAQ: ORMP) was established in 2006, and has developed a...

    Oramed Pharmaceuticals (NASDAQ: ORMP) was estab...

    Filing Type:    PU
    Aurinia Pharmaceuticals Inc

    Aurinia Pharmaceuticals Inc

    Aurinia is a late clinical stage biopharmaceutical company focused on developing a...

    Aurinia is a late clinical stage biopharmaceuti...

    Filing Type:    PU
    Marker Therapeutics, Inc.

    Marker Therapeutics, Inc.

    We are a clinical-stage immuno-oncology company specializing in the development an...

    We are a clinical-stage immuno-oncology company...

    Filing Type:    PU
    Alkermes plc

    Alkermes plc

    Alkermes plc is a fully integrated, global biopharmaceutical company developing in...

    Alkermes plc is a fully integrated, global biop...

    Filing Type:    PU
    ACADIA Pharmaceuticals

    ACADIA Pharmaceuticals

    At ACADIA (NASDAQ: ACAD), we share a passion for improving the lives of patients w...

    At ACADIA (NASDAQ: ACAD), we share a passion fo...

    Filing Type:    PU
    Axsome Therapeutics, Inc.

    Axsome Therapeutics, Inc.

    Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing...

    Axsome Therapeutics, Inc. is a clinical-stage b...

    Filing Type:    PU
    REGENXBIO Inc.

    REGENXBIO Inc.

    REGENXBIO is a leading biotechnology company focused on the development, commercia...

    REGENXBIO is a leading biotechnology company fo...

    Filing Type:    PU
    AVROBIO, Inc.

    AVROBIO, Inc.

    AVROBIO, Inc., a leader in lentiviral-based gene therapies, is a clinical stage co...

    AVROBIO, Inc., a leader in lentiviral-based gen...

    Filing Type:    PU
    Fortress Biotech, Inc.

    Fortress Biotech, Inc.

    Fortress Biotech ("Fortress" or "the Company") is an innovative biopharmaceutical ...

    Fortress Biotech ("Fortress" or "the Company") ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.